As anticipated, HLA-G blocking antibody increased the frequency of target CLL cells in conjugation with NK-92MI cells compared to control IgG, indicating a release of the inhibitory ILT-2 signaling and restoration of IS formation (Figure 6A). This evidence concerns the gene LILRB1 and B-cell chronic lymphocytic leukemia.